5 Mid-Cap Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 Years

Below are the top mid-cap stocks in the healthcare sector in terms of EPS growth forecast for the next five years.

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) earnings per share growth forecast for the next five years is 46.09%. Alnylam Pharmaceuticals' trailing-twelve-month revenue is $50.60 million.

Molina Healthcare, Inc. (NYSE: MOH) EPS growth forecast for the next five years is 38.83%. Molina Healthcare's trailing-twelve-month revenue is $9.67 billion.

DexCom, Inc. (NASDAQ: DXCM) EPS growth forecast for the next five years is 32.50%. DexCom's trailing-twelve-month revenue is $259.20 million.

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) earnings per share growth forecast for the next five years is 31.81%. Acadia Healthcare's trailing-twelve-month revenue is $1.00 billion.

United Therapeutics Corporation (NASDAQ: UTHR) earnings per share growth forecast for the next five years is 30.40%. United Therapeutics' trailing-twelve-month revenue is $1.29 billion.